Cibus announces closing of merger with Calyxt to create industry leading precision gene editing and trait development company

Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. By combining its leading gene-editing technology and technical expertise with its innovative commercial strategy, Calyxt is pioneering a paradigm shift to deliver both healthier specialty food ingredients, such as healthier oils and high fiber wheat for consumers as well as agriculturally advantageous traits, such as herbicide tolerance to farmers. While the traits that enable these characteristics may occur naturally or through traditional agricultural technologies—these processes are imprecise and take many years, if not decades, to achieve a desired trait. Our technology enables us to precisely and specifically edit a plant genome to elicit the desired traits and characteristics, resulting in a final product that has no foreign DNA. We believe the precision, specificity, cost effectiveness and speed of our gene-editing technologies will enable us to provide meaningful disruption to the food and agriculture industries. Calyxt is located in Minneapolis-St. Paul, Minn., and is a wholly owned subsidiary of Cellectis.